LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 22.39 27.76 1168 1305 0.8945 0.9603
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 22.39 27.76 1153 1305 0.8830 0.9557
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 22.39 27.76 1181 1305 0.9045 0.9642
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 22.39 27.76 65 1305 0.0498 0.1655
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 22.39 27.76 1419 1305 1.0868 1.0302
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 24.09 27.76 32 1461 0.0219 0.0252
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 24.09 27.76 1177 1461 0.8053 0.9257
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 24.09 27.76 1147 1461 0.7847 0.9170
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 24.09 27.76 1180 1461 0.8073 0.9265
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 24.09 27.76 84 1461 0.0575 0.2137
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 24.09 27.76 1483 1461 1.0146 1.0051
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 25.79 27.76 13 1605 0.0081 -0.1216
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 25.79 27.76 1203 1605 0.7495 0.9039
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 25.79 27.76 1212 1605 0.7551 0.9063
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 25.79 27.76 1237 1605 0.7707 0.9129
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 25.79 27.76 106 1605 0.0660 0.2572
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 25.79 27.76 1553 1605 0.9675 0.9888
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 27.49 27.76 34 1723 0.0197 0.0346
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 27.49 27.76 1199 1723 0.6958 0.8819
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 27.49 27.76 1270 1723 0.7370 0.9001
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 27.49 27.76 1293 1723 0.7504 0.9059
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 27.49 27.76 100 1723 0.0580 0.2401
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 27.49 27.76 1580 1723 0.9169 0.9711
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 29.19 27.76 42 1863 0.0225 0.0706
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 29.19 27.76 1224 1863 0.6570 0.8662
MN20160318_Q01
E20